Published in PLoS One on March 15, 2012
Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ (2013) 4.17
Type I interferons in infectious disease. Nat Rev Immunol (2015) 2.37
Aerosol transmission is an important mode of influenza A virus spread. Nat Commun (2013) 1.56
Natural selection and infectious disease in human populations. Nat Rev Genet (2014) 1.48
No Major Host Genetic Risk Factor Contributed to A(H1N1)2009 Influenza Severity. PLoS One (2015) 1.38
Differences in the Epidemiology of Human Cases of Avian Influenza A(H7N9) and A(H5N1) Viruses Infection. Clin Infect Dis (2015) 1.27
Pathogenic potential of interferon αβ in acute influenza infection. Nat Commun (2014) 1.19
Lack of middle East respiratory syndrome coronavirus transmission from infected camels. Emerg Infect Dis (2015) 1.01
A systems biology approach to the effect of aging, immunosenescence and vaccine response. Curr Opin Immunol (2014) 0.93
Surfactant protein A genetic variants associate with severe respiratory insufficiency in pandemic influenza A virus infection. Crit Care (2014) 0.89
H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice. Proc Natl Acad Sci U S A (2015) 0.89
Protection from Severe Influenza Virus Infections in Mice Carrying the Mx1 Influenza Virus Resistance Gene Strongly Depends on Genetic Background. J Virol (2015) 0.89
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Dual role of commensal bacteria in viral infections. Immunol Rev (2013) 0.87
Host genetic determinants of influenza pathogenicity. Curr Opin Virol (2013) 0.85
Genetic Susceptibility Is One of the Determinants for Severe Fever with Thrombocytopenia Syndrome Virus Infection and Fatal Outcome: An Epidemiological Investigation. PLoS One (2015) 0.83
Demographic and clinical predictors of mortality from highly pathogenic avian influenza A (H5N1) virus infection: CART analysis of international cases. PLoS One (2014) 0.83
Seroprevalence of antibodies to highly pathogenic avian influenza A (H5N1) virus among close contacts exposed to H5N1 cases, China, 2005-2008. PLoS One (2013) 0.82
Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung. Vet Res (2014) 0.82
Host genetics of severe influenza: from mouse Mx1 to human IRF7. Curr Opin Immunol (2016) 0.81
Differential Susceptibilities of Human Lung Primary Cells to H1N1 Influenza Viruses. J Virol (2015) 0.79
Insight into alternative approaches for control of avian influenza in poultry, with emphasis on highly pathogenic H5N1. Viruses (2012) 0.79
The CCR5Δ32 allele is not a major predisposing factor for severe H1N1pdm09 infection. BMC Res Notes (2014) 0.79
Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections. PLoS One (2016) 0.77
Editorial commentary: Host and viral factors in emergent influenza virus infections. Clin Infect Dis (2014) 0.77
Host genetics determine susceptibility to avian influenza infection and transmission dynamics. Sci Rep (2016) 0.75
Systems biology: A tool for charting the antiviral landscape. Virus Res (2016) 0.75
Molecular determinants of influenza virus pathogenesis in mice. Curr Top Microbiol Immunol (2014) 0.75
An ENU-induced splicing mutation reveals a role for Unc93b1 in early immune cell activation following influenza A H1N1 infection. Genes Immun (2014) 0.75
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med (2010) 9.90
Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet (2010) 9.53
Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med (2005) 6.47
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 6.46
Human host factors required for influenza virus replication. Nature (2010) 5.28
Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med (2006) 5.14
Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med (2011) 4.02
Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol (1988) 3.32
Massively parallel sequencing and rare disease. Hum Mol Genet (2010) 3.28
Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ (2010) 2.96
Evidence for a heritable predisposition to death due to influenza. J Infect Dis (2008) 2.94
HLA restriction of cell-mediated lysis of influenza virus-infected human cells. Nature (1977) 2.88
Host gene influences sensitivity to interferon action selectively for influenza virus. Nature (1980) 2.88
Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J Exp Med (1978) 2.54
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
HLA and infectious diseases. Clin Microbiol Rev (2009) 2.35
Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci U S A (2007) 2.33
ABO Blood Groups and Acute Respiratory Virus Disease. Br Med J (1962) 2.30
Host genetic background strongly influences the response to influenza a virus infections. PLoS One (2009) 2.28
Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med (1979) 2.14
Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol (2009) 2.08
Deaths related to 2009 pandemic influenza A (H1N1) among American Indian/Alaska Natives - 12 states, 2009. MMWR Morb Mortal Wkly Rep (2009) 2.05
The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J Virol (2002) 2.05
Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One (2010) 2.04
Family clustering of avian influenza A (H5N1). Emerg Infect Dis (2005) 2.04
Transcriptional activation of the mouse Mx gene by type I interferon. Mol Cell Biol (1986) 2.04
Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006. J Infect Dis (2007) 1.95
The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol (2007) 1.93
The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. Euro Surveill (2009) 1.90
Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry (1995) 1.85
Protective role of beta interferon in host defense against influenza A virus. J Virol (2006) 1.80
Transgenic mice with intracellular immunity to influenza virus. Cell (1990) 1.73
Recurrent acute necrotizing encephalopathy following influenza A in a genetically predisposed family. Dev Med Child Neurol (2009) 1.64
Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J Virol (2008) 1.62
Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol (2007) 1.58
HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2. J Exp Med (1978) 1.56
The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J Virol (2011) 1.51
Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses. J Immunol (2000) 1.47
Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet (2009) 1.47
Association between secretor status and respiratory viral illness. BMJ (1991) 1.47
Lessons from the past: familial aggregation analysis of fatal pandemic influenza (Spanish flu) in Iceland in 1918. Proc Natl Acad Sci U S A (2008) 1.44
Protective role of interferon-induced Mx GTPases against influenza viruses. Rev Sci Tech (2009) 1.39
Influenza in an isolated community; an epidemic on Ocean Island. Lancet (1950) 1.35
Acute encephalopathy and encephalitis caused by influenza virus infection. Curr Opin Neurol (2010) 1.34
Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model. J Virol (2010) 1.33
Resistance of mice to mouse-adapted influenza A virus. Virology (1962) 1.33
Genetic susceptibility and resistance to influenza infection and disease in humans and mice. Expert Rev Mol Diagn (2008) 1.33
Genetic control of host resistance to infection. Trends Genet (1994) 1.30
Key concepts in genetic epidemiology. Lancet (2005) 1.29
Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors. Virology (2011) 1.28
HI antibody to various influenza viruses and adenoviruses in individuals of blood groups A and O. J Hyg (Lond) (1969) 1.24
Host gene influence on interferon action in adult mouse hepatocytes: specificity for influenza virus. Virology (1980) 1.23
HLA-linked genetic control of the specicity of human cytotoxic T-cell responses to influenza virus. J Exp Med (1979) 1.23
What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect (2010) 1.22
H5N1 influenza virus pathogenesis in genetically diverse mice is mediated at the level of viral load. MBio (2011) 1.22
Interferon-regulated influenza virus resistance gene Mx is localized on mouse chromosome 16. J Virol (1986) 1.20
Gene expression changes in the host response between resistant and susceptible inbred mouse strains after influenza A infection. Microbes Infect (2010) 1.18
Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur Respir J (2011) 1.17
Little evidence for genetic susceptibility to influenza A (H5N1) from family clustering data. Emerg Infect Dis (2007) 1.17
Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins. J Virol (2010) 1.17
Novel influenza A (H1N1) presenting as an acute febrile encephalopathy in a mother and daughter. Clin Infect Dis (2009) 1.17
Interferons, Mx genes, and resistance to influenza virus. Am J Respir Crit Care Med (1995) 1.16
The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses. J Virol (2011) 1.16
Differences in HLA antigen recognition by human influenza virus-immune cytotoxic T cells. J Immunol (1979) 1.16
A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Clin Immunol (2006) 1.13
The incidence of HI antibody to Influenza virus A2/Singapore/ 1/57 in individuals of blood groups A and O. J Immunol (1967) 1.13
Risk factors for 2009 pandemic influenza A (H1N1)-related hospitalization and death among racial/ethnic groups in New Mexico. Am J Public Health (2011) 1.05
Mx1 gene protects mice against the highly lethal human H5N1 influenza virus. Cell Cycle (2007) 1.05
Systems-based candidate genes for human response to influenza infection. Infect Genet Evol (2009) 1.04
Gene expression in lung and basal forebrain during influenza infection in mice. Genes Brain Behav (2007) 0.99
Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals. Proc Natl Acad Sci U S A (2011) 0.99
Summary of human infection with highly pathogenic avian influenza A (H5N1) virus reported to WHO, January 2003-March 2009: cluster-associated cases. Wkly Epidemiol Rec (2010) 0.98
Risk factors for cluster outbreaks of avian influenza A H5N1 infection, Indonesia. Clin Infect Dis (2011) 0.97
Sibling familial risk ratio of meningococcal disease in UK Caucasians. Epidemiol Infect (2003) 0.96
Human cytotoxic T-cell responses to type A and type B influenza viruses can be restricted by different HLA antigens. Implications for HLA polymorphism and genetic regulation. J Exp Med (1980) 0.96
ABO blood groups and viral diseases. Yale J Biol Med (1972) 0.93
Relation between blood groups and resistance to infection with influenza and spome picornaviruses. Nature (1968) 0.93
Antibodies of influenza viruses in military recruits from Argentina, Brazil and Colombia. Their relation to ABO blood group distribution. Bull World Health Organ (1970) 0.93
A quantitative genetic analysis of slow-wave sleep in influenza-infected CXB recombinant inbred mice. Behav Genet (1999) 0.91
Host genetic background and the innate inflammatory response of lung to influenza virus. Microbes Infect (2011) 0.90
Mx gene control of interferon action: different kinetics of the antiviral state against influenza virus and vesicular stomatitis virus. J Virol (1983) 0.90
The effect of ABO blood groups on the incidence of epidemic influenza and on the response to live attenuated and detergent split influenza virus vaccines. J Hyg (Lond) (1978) 0.89
Human genes and influenza. J Infect Dis (2008) 0.89
Effect of MHC class I diversification on influenza epitope-specific CD8+ T cell precursor frequency and subsequent effector function. J Immunol (2011) 0.85
Analysis of gene expression in human bronchial epithelial cells upon influenza virus infection and regulation by p38 mitogen-activated protein kinase and c-Jun-N-terminal kinase. Respirology (2008) 0.83
Genetic mapping of the Mx influenza virus resistance gene within the region of mouse chromosome 16 that is homologous to human chromosome 21. J Virol (1988) 0.81
Pathology of influenza hepatitis in susceptible and genetically resistant mice. Exp Cell Biol (1976) 0.80
Host factors and susceptibility to influenza A infection: the effect of ABO blood groups and HL-A antigens. Dev Biol Stand (1978) 0.79
Pandemic lessons from Iceland. Proc Natl Acad Sci U S A (2008) 0.78
[Genetic factors in severe cases of (H1N1) 2009 influenza]. Rev Esp Salud Publica (2011) 0.78
ABO associated genetic determinant in H1N1 influenza. Tissue Antigens (1980) 0.78
The relationship between epidemic influenza (A(H1N1) and ABO blood group. J Hyg (Lond) (1981) 0.78
INFLUENZA OBSERVATIONS IN FRAMINGHAM, MASSACHUSETTS. Am J Public Health (N Y) (1919) 0.76
Polymorphism of human blood groups and incidence of influenza A/Hong Kong (H3N2). Acta Virol (1975) 0.76
Studies of the genetic susceptibility of individuals to infection with influenza viruses. Humangenetik (1975) 0.76
A promoter-level mammalian expression atlas. Nature (2014) 6.25
IFITM3 restricts the morbidity and mortality associated with influenza. Nature (2012) 4.66
The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell (2010) 3.64
Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell (2012) 3.54
A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol (2007) 2.71
Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell (2013) 2.28
Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet (2011) 2.00
Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science (2015) 1.91
A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One (2008) 1.83
Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol (2015) 1.58
Open source clinical science for emerging infections. Lancet Infect Dis (2014) 1.47
Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog (2008) 1.41
Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet (2010) 1.41
Functional clustering and lineage markers: insights into cellular differentiation and gene function from large-scale microarray studies of purified primary cell populations. Genomics (2010) 1.26
Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Proc Natl Acad Sci U S A (2009) 1.22
Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis. J Immunol (2012) 1.21
A gene expression atlas of the domestic pig. BMC Biol (2012) 1.18
An expression atlas of human primary cells: inference of gene function from coexpression networks. BMC Genomics (2013) 1.11
Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population. Malar J (2009) 1.03
Whole genome-amplified DNA: insights and imputation. Nat Methods (2008) 1.02
Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro. High Alt Med Biol (2010) 0.99
High altitude adaptation in Daghestani populations from the Caucasus. Hum Genet (2011) 0.96
Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis. J Infect Dis (2012) 0.94
An updated systematic review of the role of host genetics in susceptibility to influenza. Influenza Other Respir Viruses (2013) 0.92
Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness. Respir Med (2006) 0.86
Modelling mutational and selection pressures on dinucleotides in eukaryotic phyla--selection against CpG and UpA in cytoplasmically expressed RNA and in RNA viruses. BMC Genomics (2013) 0.83
HIV-1 drug resistance in antiretroviral-naive individuals with HIV-1-associated tuberculous meningitis initiating antiretroviral therapy in Vietnam. Antivir Ther (2012) 0.82
Toll-like receptor 4 (TLR4) and typhoid fever in Vietnam. PLoS One (2009) 0.80
NT-proBNP does not rise on acute ascent to high altitude. High Alt Med Biol (2008) 0.80
Is somatic retrotransposition a parasitic or symbiotic phenomenon? Mob Genet Elements (2011) 0.79
Sildenafil citrate for the prevention of high altitude hypoxic pulmonary hypertension: double blind, randomized, placebo-controlled trial. High Alt Med Biol (2011) 0.79
Retinal vessel tortuosity in response to hypobaric hypoxia. High Alt Med Biol (2012) 0.79
Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitude. High Alt Med Biol (2006) 0.78
Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med (2005) 0.78
Phosphodiesterase type 5 inhibitors in the treatment and prevention of high altitude pulmonary edema. Curr Opin Investig Drugs (2007) 0.76
The citric acid cough threshold and the ventilatory response to carbon dioxide on ascent to high altitude. Respir Med (2009) 0.76
Complete genome sequence of methicillin-sensitive Staphylococcus aureus containing a heterogeneic staphylococcal cassette chromosome element. Sci China Life Sci (2013) 0.75
Measurement errors caused by incompatibility of apparatus. Eur J Anaesthesiol (2009) 0.75